Is Marker Therapeutics Inc (MRKR) overvalued? · $25.3M cap
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
This page asks whether Marker Therapeutics Inc (MRKR) looks expensive on cached numbers — not a short thesis.
No cached income statement for MRKR, so there is no earnings base to call rich or cheap.
MRKR currently screens at market cap $25.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MRKR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MRKR stock page for the full model, not this heading.
Not investment advice.